A Study of LY3471851 in Participants With Psoriasis

J1P-MC-KFAC -

The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with psoriasis.

Trial Summary

Age Range
18 - 70 years
Conditions the trial is for
Plaque Psoriasis
What the trial is testing?
LY3471851
Could I receive a Placebo?
Yes
Enrollment Goal
30
Trial Dates
Nov 26, 2019 - Jul 21, 2021
How long will I be in the trial?
The study will last up to 48 weeks and may include up to 23 visits to the study center.
Trial Phase
I

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Participants must have been diagnosed with psoriasis for at least 6 months

  • Participants must have active psoriasis plaques

  • Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)

Participants Must Not:

  • Participants must not have received certain medications for psoriasis that are applied to the skin within 14 days prior to baseline (Day 1)

  • Participants must not have received certain oral or injectable medications or light therapy for psoriasis within 4 weeks prior to baseline

  • Participants must not have taken the study drug previously

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.